S. Geraci

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

L. Rostaing, N. Kamar, M. Essig, 2018, Advances in Therapy.

Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.

D. Ardigò, C. Hendriksz, A. Lund, 2018, Molecular genetics and metabolism.

JACQUES DERRIDA AND ABRAHAM'S HERITAGE

S. Geraci, 2011 .

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis

L. de Meirleir, D. Ardigò, A. Lund, 2018, Journal of Inherited Metabolic Disease.

Musculoskeletal Pain as a Novel Complication After Posterior Tibial Nerve Block in Stroke and Traumatic Brain Injury Patients

S. Geraci, John Paul Madanat, P. Jajoo, 2011, PM & R : the journal of injury, function, and rehabilitation.

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial

L. de Meirleir, D. Ardigò, A. Lund, 2018, Journal of Inherited Metabolic Disease.

Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

U. Maggiore, K. Budde, L. Rostaing, 2022, Transplant International.

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

H. Watz, Dave Singh, B. Leaker, 2019, Respiratory Research.